SGHT
- Sight Sciences, Inc.
()
Overview
Company Summary
Sight Sciences, Inc. is a medical technology company that focuses on delivering innovative solutions in the field of ophthalmology. The company specializes in developing and commercializing devices and technologies aimed at treating common eye disorders and improving patients' quality of life.
One of Sight Sciences' primary areas of focus is glaucoma, a chronic eye disease characterized by increased pressure within the eye that can lead to optic nerve damage and vision loss. The company has developed a range of products designed to address different aspects of glaucoma management.
Firstly, Sight Sciences offers a device called the OMNI Surgical System, which combines both micro-invasive glaucoma surgery (MIGS) and cataract surgery. This system helps surgeons in treating glaucoma during the cataract surgery procedure, providing a single-step solution for patients with these concurrent conditions.
Additionally, the company has a product called the VISCO360, which is used for canaloplasty procedures. Canaloplasty is a minimally invasive glaucoma surgery that involves microcatheterization of the eye's natural drainage system to improve aqueous humor outflow and lower intraocular pressure.
Another core product offered by Sight Sciences is the TRAB360 system, designed to provide surgeons with real-time visualization and direct access into Schlemm's canal. This product aims to enhance the outcomes of traditional trabeculotomy procedures by improving surgical efficiency and accuracy.
Overall, Sight Sciences, Inc. is dedicated to developing and delivering innovative solutions for managing glaucoma and related eye disorders. Their products aim to improve surgical outcomes, enhance patients' quality of life, and provide effective treatment options for ophthalmologists worldwide.